Elizabeth A V Jones

Dr. Elizabeth A V Jones

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Cell
Verified
Journal Article
Closed access
SSSebastiaan De Schepper
Sebastiaan De Schepper
SVSimon Verheijden
Simon Verheijden
JAJavier Aguilera-Lizarraga
Javier Aguilera-Lizarraga
MVMaria Francesca Viola
Maria Francesca Viola
WBWerend Boesmans
Werend Boesmans
GBGuy Boeckxstaens
Guy Boeckxstaens

15 September 2007 in Development
Verified
Journal Article
Closed access
PDF file
JLJennifer L. Lucitti
Jennifer L. Lucitti
EJElizabeth A V Jones
Elizabeth A V Jones
CHChengqun Huang
Chengqun Huang
JCJu Chen
Ju Chen
SFScott E. Fraser
Scott E. Fraser
MDMary E. Dickinson
Mary E. Dickinson
The embryonic heart and vessels are dynamic and form and remodel while functional. Much has been learned about the genetic mechanisms underlying the development of the cardiovascular system, but we are just beginning to understand how changes in heart and vessel structure are influenced by hemodynamic forces such as shear stress. Recent work has shown that vessel remodeling in the mouse yolk sac is secondarily effected when cardiac function is reduced or absent. These findings indicate that proper circulation is required for vessel remodeling, but have not defined whether the role of circulation is to provide mechanical cues, to deliver oxygen or to circulate signaling molecules. Here, we used time-lapse confocal microscopy to determine the role of fluid-derived forces in vessel remodeling in the developing murine yolk sac. Novel methods were used to characterize flows in normal embryos and in embryos with impaired contractility (Mlc2a-/-). We found abnormal plasma and erythroblast circulation in these embryos, which led us to hypothesize that the entry of erythroblasts into circulation is a key event in triggering vessel remodeling. We tested this by sequestering erythroblasts in the blood islands, thereby lowering the hematocrit and reducing shear stress, and found that vessel remodeling and the expression of eNOS (Nos3) depends on erythroblast flow. Further, we rescued remodeling defects and eNOS expression in low-hematocrit embryos by restoring the viscosity of the blood. These data show that hemodynamic force is necessary and sufficient to induce vessel remodeling in the mammalian yolk sac.

18 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
SSSteven Simmonds
Steven Simmonds
ICIlona Cuijpers
Ilona Cuijpers
SHStephane Heymans
Stephane Heymans
EJElizabeth A V Jones
Elizabeth A V Jones
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be classified into three groups based on the percentage of the ejection fraction (EF): heart failure with reduced EF (HFrEF), heart failure with mid-range—also called mildly reduced EF— (HFmrEF), and heart failure with preserved ejection fraction (HFpEF). HFmrEF can progress into either HFrEF or HFpEF, but its phenotype is dominated by coronary artery disease, as in HFrEF. HFrEF and HFpEF present with differences in both the development and progression of the disease secondary to changes at the cellular and molecular level. While recent medical advances have resulted in efficient and specific treatments for HFrEF, these treatments lack efficacy for HFpEF management. These differential response rates, coupled to increasing rates of HF, highlight the significant need to understand the unique pathogenesis of HFrEF and HFpEF. In this review, we summarize the differences in pathological development of HFrEF and HFpEF, focussing on disease-specific aspects of inflammation and endothelial function, cardiomyocyte hypertrophy and death, alterations in the giant spring titin, and fibrosis. We highlight the areas of difference between the two diseases with the aim of guiding research efforts for novel therapeutics in HFrEF and HFpEF.

1 December 2018 in Cell Metabolism
Verified
Journal Article
Closed access
JKJoanna Kalucka
Joanna Kalucka
LBLaura Bierhansl
Laura Bierhansl
NCNadine Vasconcelos Conchinha
Nadine Vasconcelos Conchinha
RMRindert Missiaen
Rindert Missiaen
IEIlaria Elia
Ilaria Elia
PCPeter Carmeliet
Peter Carmeliet

22 July 2016 in Circulation Research
Verified
Journal Article
Open access
PDF file
MMMarwa M. Mahmoud
Marwa M. Mahmoud
HKHyejeong Rosemary Kim
Hyejeong Rosemary Kim
RXRouyu Xing
Rouyu Xing
SHSarah Hsiao
Sarah Hsiao
AMAkiko Mammoto
Akiko Mammoto
Paul EvansPaul Evans
Paul Evans
Rationale:: Blood flow–induced shear stress controls endothelial cell (EC) physiology during atherosclerosis via transcriptional mechanisms that are incompletely understood. The mechanosensitive transcription factor TWIST is expressed during embryogenesis, but its role in EC responses to shear stress and focal atherosclerosis is unknown. Objective:: To investigate whether TWIST regulates endothelial responses to shear stress during vascular dysfunction and atherosclerosis and compare TWIST function in vascular development and disease. Methods and Results:: The expression and function of TWIST1 was studied in EC in both developing vasculature and during the initiation of atherosclerosis. In zebrafish, twist was expressed in early embryonic vasculature where it promoted angiogenesis by inducing EC proliferation and migration. In adult porcine and murine arteries, TWIST1 was expressed preferentially at low shear stress regions as evidenced by quantitative polymerase chain reaction and en face staining. Moreover, studies of experimental murine carotid arteries and cultured EC revealed that TWIST1 was induced by low shear stress via a GATA4-dependent transcriptional mechanism. Gene silencing in cultured EC and EC-specific genetic deletion in mice demonstrated that TWIST1 promoted atherosclerosis by inducing inflammation and enhancing EC proliferation associated with vascular leakiness. Conclusions:: TWIST expression promotes developmental angiogenesis by inducing EC proliferation and migration. In addition to its role in development, TWIST is expressed preferentially at low shear stress regions of adult arteries where it promotes atherosclerosis by inducing EC proliferation and inflammation. Thus, pleiotropic functions of TWIST control vascular disease and development.

1 December 2006 in Physiology
Verified
Journal Article
Closed access
PDF file
EJElizabeth A V Jones
Elizabeth A V Jones
FNFerdinand le Noble
Ferdinand le Noble
AEAnne Eichmann
Anne Eichmann
Vascular network remodeling, angiogenesis, and arteriogenesis play an important role in the pathophysiology of ischemic cardiovascular diseases and cancer. Based on recent studies of vascular network development in the embryo, several novel aspects to angiogenesis have been identified as crucial to generate a functional vascular network. These aspects include specification of arterial and venous identity in vessels and network patterning. In early embryogenesis, vessel identity and positioning are genetically hardwired and involve neural guidance genes expressed in the vascular system. We demonstrated that, during later stages of embryogenesis, blood flow plays a crucial role in regulating vessel identity and network remodeling. The flow-evoked remodeling process is dynamic and involves a high degree of vessel plasticity. The open question in the field is how genetically predetermined processes in vessel identity and patterning balance with the contribution of blood flow in shaping a functional vascular architecture. Although blood flow is essential, it remains unclear to what extent flow is able to act on the developing cardiovascular system. There is significant evidence that mechanical forces created by flowing blood are biologically active within the embryo and that the level of mechanical forces and the type of flow patterns present in the embryo are able to affect gene expression. Here, we highlight the pivotal role for blood flow and physical forces in shaping the cardiovascular system.